The Food and Drug Administration has granted emergency use authorization for Gilead Sciences’ Remdesivir drug to treat Covid-19, the disease caused by coronavirus, President Donald Trump announced Friday. Trump made the announcement in the Oval Office alongside Gilead CEO Daniel O’Day. “We want to thank the collaborators that brought Remdesivir to this point and many of our people that have been part of this, in fact, the caregivers,” O’Day told reporters. He added that the company is donating 1 million vials of Remdesivir. Gilead shares pared losses on the news,…
Read More